FOXP3 and PTEN hamartoma tumor syndrome: There was a similar frequency of S6-phosphorylated FOXP3+ cells in control subjects and patients with PHTS (Fig 4, D and E), indicating that despite the PTEN insufficiency/dysfunction, the signaling pathway downstream of mTORC1 is not hyperactivated.